Defective death receptor signaling as a cause of tumor immune escape

Seminars in Cancer Biology
L E French, J Tschopp

Abstract

Death receptors are a subgroup of TNF-receptor family members that can trigger caspase-8 activation and apoptosis upon interaction with their selective ligands. One of the death receptors, Fas (CD95) and its ligand is critically involved in the regulation of immune homeostasis and effectorfunction. Fas-mediated cell death is a major pathway of cytolytic T-cell-mediated death that is involved in specific killing of tumor cells. Recent investigations summarized herein have shown that defective Fas-signaling due to receptor downregulation or dysfunction, or intracellular inhibition by FLIP (FLICE inhibitory protein) can interfere with Fas-mediated tumor cell death, and thereby favor tumor immune escape.

Citations

Apr 14, 2004·The Journal of Experimental Medicine·Stephan MathasBernd Dörken
Apr 7, 2004·The Journal of Experimental Medicine·Ilaria GuasparriEthel Cesarman
Oct 27, 2005·Cancer Biotherapy & Radiopharmaceuticals·Su-hu LiuWang-Gang Zhang
Jul 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mala ChakrabortyJames W Hodge
Dec 24, 2003·BMC Cancer·Arslan AkhmedkhanovPaolo Toniolo
Jul 30, 2003·Expert Opinion on Therapeutic Targets·Olivier Micheau
Jun 19, 2016·Journal of Theoretical Biology·Khaphetsi Joseph MahasaLisette de Pillis
Dec 27, 2005·Expert Review of Anticancer Therapy·Camillo Porta
Aug 15, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Aleksandra KornilukVioletta Dymicka-Piekarska
Mar 6, 2017·Critical Reviews in Oncology/hematology·Enrique ChajonRenaud De Crevoisier
Oct 3, 2003·Journal of Molecular Recognition : JMR·Roberta CastinoCiro Isidoro
Jan 6, 2018·Cancers·Neus Martinez-BoschPilar Navarro
Mar 23, 2004·Annals of the New York Academy of Sciences·Ariane SharifHervé Chneiweiss
Jan 8, 2003·International Journal of Cancer. Journal International Du Cancer·Annette PaschenDirk Schadendorf
May 9, 2006·Cancer Immunology, Immunotherapy : CII·Thomas B TomasiA Nazmul H Khan
Feb 13, 2008·Cancer Immunology, Immunotherapy : CII·Stephanie S Tseng-RogenskiMartin G Sanda
Jun 1, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yoon Kyung JeonChul-Woo Kim
Oct 11, 2005·Apoptosis : an International Journal on Programmed Cell Death·S-Y Sun
Mar 14, 2009·The Tohoku Journal of Experimental Medicine·Huajie ZongXianghuo He
Nov 14, 2014·The FEBS Journal·Kate Beishline, Jane Azizkhan-Clifford
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jérôme ThierySalem Chouaib
Jun 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mala ChakrabortyJames W Hodge
Apr 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hayato NakagawaShin Maeda
Jul 2, 2005·World Journal of Gastroenterology : WJG·Tong XuXi-Shan Hao
Jun 28, 2018·Pathology Oncology Research : POR·Yi-Ting ChenAij-Lie Kwan
Oct 21, 2018·Cell Death and Differentiation·Michelle N MessmerAndrew Oberst
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter HorakMichael Krainer
Dec 29, 2020·Genome Research·Kiley GraimOlga G Troyanskaya
Sep 23, 2003·Cellular Signalling·James F Curtin, Thomas G Cotter
Oct 14, 2003·Biochemical Pharmacology·François RenaultHervé Chneiweiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.